Try our beta test site
1 study found for:    A7471009
Show Display Options
Rank Status Study
1 Completed ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dacomitinib (PF-00299804);   Drug: Active Comparator (erlotinib);   Drug: Placebo erlotinib;   Drug: Placebo PF00299804

Study has passed its completion date and status has not been verified in more than two years.